Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 139, 2019 - Issue 7
Submit an article Journal homepage
321
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late?

Elizabeth AmarilloOtolaryngology Department, Complejo Hospitalario La Mancha Centro, Alcázar de San Juan, Spain; ;Rey Juan Carlos University, International doctoral school. Madrid, Spain; Correspondence[email protected]
,
Andres NavarroOtolaryngology Department, Fuenlabrada Universitary Hospital. Fuenlabrada, Spain
,
Estefania Hernández-GarcíaRey Juan Carlos University, International doctoral school. Madrid, Spain; ;Otolaryngology Department, Fuenlabrada Universitary Hospital. Fuenlabrada, Spain
&
Guillermo PlazaRey Juan Carlos University, International doctoral school. Madrid, Spain; ;Otolaryngology Department, Fuenlabrada Universitary Hospital. Fuenlabrada, Spain
Pages 632-635 | Received 26 Mar 2019, Accepted 28 Apr 2019, Published online: 24 May 2019

References

  • Rauch SD. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am. 2004;37:1061–1074.
  • Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1–17.
  • Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001;22:18–23.
  • Haynes DS, O’Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007;117:3–15.
  • Moon IS, Lee JD, Kim J, et al. Intratympanic dexamethasone is an effective method as a salvage treatment in refractory sudden hearing loss. Otol Neurotol. 2011;32:1432–1436.
  • Kakehata S, Sasaki A, Oji K, et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol. 2006;27:604–608.
  • Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008;29:453–460.
  • Qiang Q, Wu X, Yang T, et al. A comparison between systemic and intratympanic steroid therapies as initial therapy for idiopathic sudden sensorineural hearing loss: a meta-analysis. Acta Otolaryngol. 2017;137:598–605.
  • Park MK, Lee CK, Park KH, et al. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2011;145:1016–1021.
  • Gundogan O, Pinar E, Imre A, et al. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness. Otolaryngol Head Neck Surg. 2013;149:753–758.
  • Lim HJ, Kim YT, Choi SJ, et al. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Otolaryngol Head Neck Surg. 2013;148:121–127.
  • Battaglia A, Lualhati A, Lin H, et al. A prospective multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: a 139 patient follow-up. Otol Neurotol. 2014;35:1091–1098.
  • Hobson CE, Alexander TH, Harris JP. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone. Curr Opin Otolaryngol Head Neck Surg. 2016;24:407–412.
  • Han X, Yin X, Du X, Sun C. Combined intratympanic and systemic use of steroids as a first-line treatment for sudden sensorineural hearing loss: a meta-analysis of randomized, controlled trials. Otol Neurotol. 2017;38:487–495.
  • Herrera M, García Berrocal JR, García Arumí A, et al. Actualización del consenso sobre el diagnóstico y tratamiento de la sordera súbita idiopática [Consensus update about idiopathyc sudden hearing loss diagnosis and treatment]. Acta Otorrinolaringol Esp. 2018. doi:10.1016/j.otorri.2018.04.010
  • Amarillo E, Hernando M, Eisenberg G, et al. Eficacia del corticoide intratimpánico como tratamiento de rescate en sordera súbita neurosensorial idiopática [Intratympanic steroids as rescue treatment in idiopathic sudden hearing loss]. Acta Otorrinolaringol Esp. 2018. doi:10.1016/j.otorri.2018.04.009
  • Plaza G, Herraiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surgery. 2007;137:74–78.
  • Attanasio G, Covelli E, Cagnoni L, et al. Does age influence the success of intra-tympanic steroid treatment in idiopathic sudden deafness? Acta Otolaryngol. 2015;135:969–973.
  • Hara JH, Zhang JA, Gandhi KR, et al. Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss. Laryngoscope Investig Otolaryngol. 2018;3:73–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.